AN AUDIT OF ADHERENCE TO ANTI-TNF THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

被引：2
|
作者：
Duncan, J. [1 ]
Sastrillo, M. [1 ]
Baker, J. [2 ]
Younge, L. [2 ]
Anderson, S. [1 ]
Lindsay, J. [2 ]
Sanderson, J. [1 ]
Irving, P. [1 ]
机构：
[1] Guys & St Thomas NHS Fdn Trust, Dept Gastroenterol, London, England
[2] Barts & London NHS Trust, Dept Gastroenterol, London, England
来源：
GUT | 2011年 / 60卷
关键词：
Adalimamab; Adherence; Anti-TNF therapy; Inflammatory Bowel Disease; infliximab; Medication Adherence Report Scale;
D O I：
10.1136/gut.2011.239301.300
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Inflammatory and cancerous skin lesions in inflammatory bowel disease patients treated with anti-TNF therapy
    Ocepek, A.
    Drobez, C. Pernat
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S252 - S253
  • [22] Treatment Adherence of Anti-TNF Drugs in the Patients with Inflammatory Bowel Disease: A Scale Development Study
    Basak, Nur
    Uran, Berna Nilgun Ozgursoy
    Yuksel, Elif Saritas
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2022, 33 (04): : 336 - +
  • [23] ANTI-TNF INDUCED LYMPHOCYTOSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Soufleris, Konstantinos
    Kafalis, Nikolaos
    Fasoulas, Konstantinos
    Pilpilidis, Ioannis
    Lazaraki, Georgia
    Markala, Dimitra
    Tzilves, Dimitris
    GASTROENTEROLOGY, 2019, 156 (06) : S635 - S635
  • [24] Anti-TNF induced lupus in patients with inflammatory bowel disease
    Picardo, S.
    So, K.
    Venugopal, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 109 - 109
  • [25] Risk of Lymphoma Associated with Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: Implications for Therapy
    Dahmus, Jessica
    Rosario, Michelle
    Clarke, Kofi
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2020, 13 : 339 - 350
  • [26] Cytomegalovirus, inflammatory bowel disease, and anti-TNFα
    Campos, Sara T.
    Portela, Francisco A.
    Tome, Luis
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2017, 32 (05) : 645 - 650
  • [27] Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with Inflammatory Bowel Disease
    Theodoraki, E.
    Orfanoudaki, E.
    Foteinogiannopoulou, K.
    Andreou, N. P.
    Gazouli, M.
    Koutroubakis, I.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I354 - I355
  • [28] Genetic association of primary nonresponse to anti-TNFα therapy in patients with inflammatory bowel disease
    De, Tanima
    Zhang, Honghong
    Alarcon, Cristina
    Lec, Bianca
    Avitia, Juan
    Smithberger, Erin
    Chen, Chuyu
    Horvath, Minnie
    Kwan, Sara
    Young, Mary
    Adhikari, Sarbani
    Kwon, John
    Pacheco, Jennifer
    Jarvik, Gail
    Wei, Wei-Qi
    Mentch, Frank
    Hakonarson, Hakon
    Sleiman, Patrick
    Gordon, Adam
    Harley, John
    Linneman, Jim
    Hebbring, Scott
    Parisiadou, Loukia
    Perera, Minoli A.
    PHARMACOGENETICS AND GENOMICS, 2022, 32 (01): : 1 - 9
  • [29] Serial Tuberculosis Screening in Inflammatory Bowel Disease Patients Receiving Anti-TNFα Therapy
    Abreu, Candida
    Afonso, Joana
    Dias, Claudia Camila
    Ruas, Rogerio
    Sarmento, Antonio
    Magro, Fernando
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (10): : 1223 - 1229
  • [30] EXCESSIVE WEIGHT GAIN IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS ON ANTI-TNF THERAPY
    Mitchel, Elana
    Huang, Jing
    Zemel, Babette
    Baldassano, Robert N.
    Albenberg, Lindsey
    Denburg, Michelle
    GASTROENTEROLOGY, 2021, 160 (06) : S527 - S528
12345